Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014.
- 1 of 1 copy available at Evergreen Indiana.
0 current holds with 1 total copy.
View other formats and editions
|Location||Call Number / Copy Notes||Barcode||Shelving Location||Status||Due Date|
|Indiana State Library - Indianapolis||ISLM Y 4.C 73/8:113-132 (Text)||2063-1117||Online document||Available||-|
- Physical Description: 1 online resource (v, 146 pages)
- Publisher: Washington : U.S. Government Publishing Office, 2016.
|General Note:|| Title from title screen (viewed on Mar. 31, 2016).
Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
"Serial No. 113-132."
|Bibliography, etc. Note:|| Includes bibliographical references.
Search for related items by subject
|Subject:||Generic drugs > Labeling > United States.
Drugs > Safety regulations > United States.
Warning labels > Government policy > United States.